Basilea Pharmaceutica AG (SWX:BSLN)
52.00
+0.30 (0.58%)
Aug 15, 2025, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 637.94 million as of August 15, 2025. Its market cap has increased by 34.13% in one year.
Market Cap
637.94M
Enterprise Value
628.90M
Revenue
208.54M
Ranking
n/a
PE Ratio
8.93
Stock Price
52.00
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 637.94M, an increase of 19.62%. That is a compound annual growth rate of 0.84%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 211.51B |
Novartis AG | 186.29B |
Lonza Group AG | 38.57B |
Alcon | 34.30B |
Galderma Group AG | 31.34B |
Sandoz Group AG | 20.62B |
Straumann Holding AG | 16.52B |
Sonova Holding AG | 13.47B |